Loading...
Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: Rationale for its use in combination therapy
Melanoma, a highly aggressive form of cancer, is notoriously resistant to available therapies. Methotrexate (MTX), an antifolate, competitively inhibits DNA synthesis and is effective for several types of cancer. In cutaneous T-cell lymphoma (CTCL), MTX increases Fas death receptor by decreasing Fas...
Na minha lista:
| Udgivet i: | Arch Biochem Biophys |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4319533/ https://ncbi.nlm.nih.gov/pubmed/24862567 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.abb.2014.04.019 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|